Bisphosphonates and atrial fibrillation: Systematic review and meta-analysis

Yoon Kong Loke, Vinodh Jeevanantham, Sonal Singh

Research output: Contribution to journalArticlepeer-review

Abstract

We identified two case-control studies, one of which found an association between bisphosphonate exposure (ever users) and atrial fibrillation (adjusted OR 1.86; 95 CI 1.09, 3.15) while the other showed no association (adjusted OR 0.99; 95 CI 0.90, 1.10). Both studies failed to demonstrate a significant association in 'current' users.We did not find a significant increase in the risk of stroke (three trial datasets; OR 1.00; 95 CI 0.82, 1.22; p0.99; I20) or cardiovascular mortality (three trial datasets; OR 0.86; 95 CI 0.66, 1.13; p0.28; I231).

Original languageEnglish (US)
Pages (from-to)219-228
Number of pages10
JournalDrug Safety
Volume32
Issue number3
DOIs
StatePublished - Apr 13 2009

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Bisphosphonates and atrial fibrillation: Systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this